BusinessUpdated 24 min ago
U.S. FDA issues VAI classification to Natco Pharma’s FDF unit in Vizag

VAI is one of the three classifications, the U.S. FDA issues implying objectionable conditions or practices were found, during the inspection, but the regulator is not prepared to take or recommend any administrative or regulatory action
Continue reading on The Hindu
Read full story Hello Headlines links you to the original publisher for the full story.


